Indian Emulsifiers Approves Rs. 51 Crore Rights Issue and Investment in Chemical Brothers Enterprises

Indian Emulsifiers Approves Rs. 51 Crore Rights Issue and Investment in Chemical Brothers Enterprises

Indian Emulsifiers Approves Rs. 51 Crore Rights Issue and Investment in Chemical Brothers Enterprises​

Indian Emulsifiers Limited announced significant strategic approvals following its Board meeting on May 16, 2026. The Board approved a fundraising round via a rights issue of equity shares and also approved a substantial investment in Chemical Brothers Enterprises Private Limited.

The Board of Directors approved the issuance and allotment of Equity Shares, each having a face value of Rs. 10.00. This fundraising is structured as a rights issue and targets an aggregate amount up to Rs. 51,00,00,000 (Rupees Fifty One Crores Only) to the eligible equity shareholders of the company.

To facilitate this capital raise, the Board also constituted a Rights Issue Committee. The committee consists of Mr. Yash Tikekar (Chairman), Mr. Rajaram Gordhanlal Agarwal (Member), and Mr. Rajesh Madhukar Joshi (Member). This committee is authorized to appoint various intermediaries and take all actions necessary for the purpose and connection with the Rights Issue.

Investment in Chemical Brothers Enterprises​

Separately, the Board of Directors approved the investment in Chemical Brothers Enterprises Private Limited, which holds 3,70,370 equity shares. This investment represents 10.99% of the paid-up share capital of the target company, with a total consideration of Rs. 600 Lakhs.

Indian Emulsifiers Limited plans to utilize the proceeds from the Rights Issue to fund this investment. The acquisition involves the purchase of fresh equity shares of Chemical Brothers by Indian Emulsifiers Limited.

Chemical Brothers Enterprises Private Limited, incorporated on August 22, 2014, is engaged in the wholesale trading and distribution of chemicals and chemical products. The company maintains customer relationships in over 15 countries, spanning North America, South America, Europe, the Middle East, Indian Sub-continent, Asia, and Australia.

The investment aims to consolidate export revenues directly within Indian Emulsifiers Limited and eliminate a related party structure currently in place for certain export sales.

Key Transaction Details​

The details regarding the two major transactions approved by the Board are summarized below:

FeatureRights Issue (Fundraising)Investment in Chemical Brothers
InstrumentEquity SharesFresh Equity Shares
Face Value/PriceRs. 10.00 per shareRs. 162 per share
Target Amount/ConsiderationUp to Rs. 51,00,00,000Rs. 600 Lakhs
Shares/StakeN/A (To eligible shareholders)3,70,370 shares (10.99% post-issue stake)
Purpose of FundsCapital raise for the companyTo acquire shares of Chemical Brothers

The financial history of Chemical Brothers Enterprises Private Limited shows its turnover:

YearTurnover (Rs. In Lakhs)
2022-235062.59
2023-244997.67
2024-255523.28

The Board Meeting concerning these business items commenced at 11:00 AM and concluded at 3:15 PM.

IEML Stock Price Movement​

On Friday, Indian Emulsifiers Limited shares edged higher to close at ₹78.00, marking a gain of 2.51% for the day. The stock finished the session on a strong note, with a total traded volume reaching 19,000 shares.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top